How Are the Lock and Key and Induced Fit Models Different?

The lock and key model treats an enzyme and its substrate as rigid, pre-shaped partners that fit together perfectly without either one changing shape. The induced fit model says the enzyme is flexible: it adjusts its shape when the substrate arrives, wrapping around it and repositioning key parts of its structure to carry out the reaction. That single difference, rigidity versus flexibility, changes how we understand nearly everything about enzyme behavior, from how enzymes pick the right molecule to why some drugs work and others fail. The real story, as researchers have discovered, is even more interesting than a simple choice between the two models.

The Lock and Key Model and What It Misses

Emil Fischer proposed the lock and key idea in the 1890s, and for a first attempt at explaining enzyme specificity it was remarkably useful. The core claim is simple: an enzyme’s active site has a fixed three-dimensional shape, and only a substrate with the matching shape can fit into it, like a key sliding into a lock. This explained why enzymes are selective. Amylase breaks down starch but not protein, because the protein molecule has the wrong shape to enter amylase’s active site.

The model works well as a first approximation, and it correctly predicts that shape matters for binding. But it runs into problems when you look closely at what actually happens inside the active site. Many enzymes bind molecules that are shaped similarly to the correct substrate but are chemically wrong. If the active site were truly rigid, there would be no way for the enzyme to distinguish between two molecules of nearly identical shape but different chemistry. The lock and key model also cannot explain why some enzymes seem to tighten their grip on the right substrate while letting the wrong one slip away. Something more is going on.

How Induced Fit Works

Daniel Koshland proposed the induced fit model in 1958 to account for the flexibility that the lock and key model ignored. The idea is that when the correct substrate approaches and makes initial contact with the enzyme, the enzyme changes shape. Loops of protein fold inward, catalytic amino acids swing into position, and the active site closes around the substrate. The enzyme and substrate together form a tighter, more precise complex than either would adopt alone.

Hexokinase, the enzyme that attaches a phosphate group to glucose at the start of sugar metabolism, is probably the most famous textbook example. Crystal structures of yeast hexokinase show the enzyme in an open conformation when no glucose is present. When glucose binds, two large domains of the protein swing together in a hinge-like motion, closing around the sugar molecule and repositioning the catalytic machinery.¹ That closing motion is not decoration. It excludes water from the active site, which prevents the enzyme from wasting energy by transferring the phosphate group to a water molecule instead of to glucose.

This shape change also explains something the lock and key model struggled with: how enzymes handle molecules that are close in shape but chemically wrong. In the induced fit picture, the wrong molecule may land in the active site, but it fails to trigger the full conformational change needed to align the catalytic residues. Without that alignment, the chemistry does not happen efficiently, and the imposter slips away.

The Molecular Switch for Specificity

Research on DNA polymerases has given one of the clearest pictures of how induced fit sharpens enzyme accuracy. When the correct nucleotide enters the polymerase’s active site, the enzyme closes around it slowly enough that the nucleotide becomes committed to the forward chemical reaction. The enzyme essentially traps the right substrate by closing the exit. When the wrong nucleotide binds, the enzyme reopens quickly, releasing the mismatch before chemistry can occur. The conformational change acts like a forward/reverse switch: the right substrate gets pushed forward, and the wrong one gets ejected.²

This means specificity is not just about whether a molecule can physically fit into the active site, which is what the lock and key model predicts. It is about what happens after initial binding: the speed of the shape change, the stability of the closed complex, and whether the enzyme holds onto the substrate long enough for the reaction to proceed. The rate at which the enzyme opens back up to release a bound molecule turns out to be a key factor in choosing the right substrate over the wrong one.²

A similar principle shows up in FEN1, an enzyme involved in DNA repair. Single-molecule experiments revealed that FEN1 physically bends the DNA strand it is examining, and only a correctly structured DNA flap triggers the mutual locking of both the protein and DNA into the reactive conformation. This sculpting happens extremely fast, at a rate limited only by how quickly the molecules can diffuse together, and it suppresses cleavage of the wrong DNA targets with remarkable precision.³

When Flexibility Itself Affects the Chemistry

Induced fit is not free. How much the active site flexes after the substrate binds can directly influence how well the enzyme carries out the chemical step. Studies on two related enzymes that break down antibiotics, called metallo-β-lactamases, illustrate this tradeoff. One of the two enzymes, L1, has a rigid loop covering its active site. The other, NDM-1, has a more flexible version of the same loop. In the more rigid L1 system, the substrate gets activated more efficiently: the key atoms line up consistently, and the energy barrier for the chemical reaction is lower. In NDM-1, the extra flexibility means only about a third of the enzyme-substrate complexes reach the same level of substrate activation at any given moment, while the rest sit in less productive arrangements.⁴

So flexibility is a double-edged feature. Too little of it and the enzyme looks like a lock and key system that may struggle to recognize a range of substrates. Too much of it and the active site becomes sloppy, sampling many arrangements and hitting the productive one only some of the time. Evolution appears to tune this balance differently depending on what the enzyme needs to do.

Conformational Selection Complicates the Picture

By the early 2000s, researchers realized that induced fit and lock and key were not the only possibilities. A third model, called conformational selection, proposes that the enzyme already samples many different shapes on its own, without the substrate present. The substrate does not force a shape change; instead, it captures one of the shapes the enzyme naturally adopts. The substrate essentially selects a pre-existing conformation rather than inducing a new one.

Distinguishing conformational selection from induced fit experimentally is tricky, and a common mistake is to try doing it by comparing rate constants. A quantitative analysis showed that the correct way to distinguish the two pathways is to measure the flux of molecules going through each one. What emerges is surprising: in many real systems, both pathways operate at the same time. At low substrate concentrations, conformational selection tends to dominate, because the enzyme has time to sample shapes on its own before a substrate molecule shows up. At high substrate concentrations, induced fit dominates, because substrate molecules are abundant enough to bind the enzyme before it has time to reach the “right” shape independently.⁵

This means the question “is it induced fit or conformational selection?” often does not have a single answer, even for one enzyme. It depends on the conditions. The two mechanisms are extreme ends of a spectrum, and most real binding events fall somewhere in between.

Same Protein Family, Opposite Mechanisms

If the mechanism can shift with conditions, can closely related proteins also land on different sides of the spectrum? Yes. A striking example comes from the proteases of two mosquito-borne viruses, dengue (DENV) and Zika (ZIKV). These two enzymes share high structural similarity, yet single-molecule fluorescence experiments showed they use opposite binding mechanisms for the same competitive ligands. The Zika protease follows an induced fit pathway, while the dengue protease follows conformational selection.⁶

This result matters beyond virology. It shows that you cannot predict the binding mechanism just by looking at a protein’s overall structure. Small differences in sequence and dynamics can tip an enzyme toward one mechanism or the other. For drug designers, this means that a drug optimized to block one viral protease by exploiting its induced fit dynamics may not work against a structurally similar relative that uses conformational selection.

Switching Between Mechanisms in Real Time

Perhaps the most dramatic illustration of flexibility in binding mechanism comes from riboswitches, stretches of RNA in bacteria that change shape when they detect a specific small molecule and thereby switch genes on or off. A manganese-sensing riboswitch was studied using single-molecule fluorescence, and the results showed that the binding pathway itself depends on what other ions are around. When the riboswitch encounters manganese alone, it follows an induced fit route: the manganese binds first, and then the RNA folds into its active shape. But when magnesium is present at physiological concentrations, it pre-folds the riboswitch into something close to the active conformation. Manganese then binds to this pre-folded form, which is conformational selection. Magnesium essentially flips the switch between the two mechanisms.⁷

This finding underscores that the binding mechanism is not a fixed property written into the protein or RNA sequence. It can change depending on the environment, the concentration of partners, and the presence of other molecules. Treating induced fit and lock and key as permanent labels for a given enzyme oversimplifies what is actually a dynamic and context-dependent process.

Intrinsically Disordered Proteins Push the Boundaries Further

Both the lock and key and induced fit models were built around enzymes that have a stable folded structure when they are alone. But a large fraction of the proteins in your cells, called intrinsically disordered proteins, have no stable structure in isolation at all. They exist as floppy, constantly shifting chains. When these proteins meet their binding partner, they can undergo a disorder-to-order transition, folding into a defined shape only upon contact.⁸

Neither the lock and key model nor the classic induced fit model captures this well. A lock has a fixed shape; an induced fit enzyme starts folded and adjusts. A disordered protein starts unfolded and may build its entire binding surface from scratch around the partner. Research on these proteins shows they can use various combinations of induced fit and conformational selection during binding, with the balance depending on how much pre-formed structure exists in the disordered chain and what the binding partner looks like.⁹

A review of the literature on disordered protein binding found that there is no single common mechanism that explains all the different binding modes observed experimentally. Some disordered proteins bind fast, some bind slowly; some gain structure before docking, some gain it after. The kinetic and thermodynamic properties vary widely from system to system.¹⁰ This diversity means that any attempt to sort molecular recognition into just two neat categories will leave out a great deal of real biology.

Why Drug Designers Care About the Difference

If you are trying to design a molecule that blocks an enzyme, the distinction between a rigid active site and a flexible one changes your strategy completely. A pure lock and key target is relatively straightforward: figure out the shape of the keyhole and design a molecule that plugs it. But if the enzyme changes shape when something binds, the “keyhole” you need to block may not exist in the enzyme’s resting structure. It only appears when the right molecule arrives and triggers the conformational change.

HIV-1 protease is a well-studied case. The enzyme opens and closes around its substrates and inhibitors through an induced fit mechanism. A substrate or drug first binds in the open conformation, and then the enzyme closes around it. How quickly and tightly the enzyme closes affects both the catalytic rate and the effectiveness of inhibitors. Drug resistance mutations in HIV-1 protease often work not by reshaping the active site in a static sense, but by altering the dynamics of that opening and closing motion, making it harder for the inhibitor drug to trigger the full closure while still allowing the natural substrate through.¹¹

A newer frontier involves “cryptic” binding pockets, sites on a protein surface that are hidden in the resting structure and only open up when the protein moves. These pockets are invisible in a static crystal structure but can be revealed through computer simulations that mimic the strong induced fit effects of ligands. Researchers have developed enhanced sampling techniques that deliberately perturb flexible loops to expose these hidden pockets, opening up new targets for drugs that would be completely missed by a lock and key approach.¹²

Common Misconceptions Worth Correcting

The most widespread misunderstanding is that the induced fit model replaced the lock and key model and the story ended there. Textbooks often present the two models as historical stages, with lock and key as the old wrong idea and induced fit as the new correct one. The reality is messier. Some binding events genuinely look like lock and key: the enzyme is already in the right shape and the substrate slots in with minimal rearrangement. Some binding events are textbook induced fit. Many are a blend of conformational selection and induced fit, with the balance shifting depending on substrate concentration and environmental conditions.

Another misconception is that you can tell which mechanism an enzyme uses just by comparing crystal structures of the enzyme alone versus the enzyme bound to substrate. If the two structures look different, people assume induced fit. But the enzyme in the unbound crystal may simply have been frozen in one of many shapes it naturally samples. The substrate might have selected that particular shape rather than inducing it. Distinguishing the two requires kinetic measurements, not just static snapshots. Single-molecule fluorescence techniques have become especially valuable here, because they can watch individual molecules in real time and track whether the shape change happens before or after binding.³

A subtler misconception involves rate constants. Researchers sometimes try to decide between induced fit and conformational selection by looking at which pathway has faster individual rate constants. But the correct approach, as demonstrated quantitatively, is to compare the total flux of molecules through each pathway, because both pathways can carry significant flux even when their individual rate constants suggest one should dominate.⁵ Getting this wrong can lead drug designers down the wrong path when trying to exploit a particular binding mechanism.